Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.73 |
| ▸ | BCHE | P06276 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | MAOB | P27338 | 4/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.62 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.62 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.62 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.62 |
| ▸ | ACHE | P22303 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31233508 | 1.00 | MAPT (0.73) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL17047852 | 1.00 | MAPT (0.73) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL25202121 | 1.00 | MAPT (0.73) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL30383301 | 1.00 | MAPT (0.73) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL30382962 | 0.89 | MAPT (0.60) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL25190924 | 0.89 | MAPT (0.73) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL12700438 | 0.89 | MAPT (0.60) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL25184971 | 0.89 | MAPT (0.60) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL25221715 | 0.88 | MAOB (0.71) | MAPTBCHECYP2C19MAOBCYP1B1 | |
| SCHEMBL25195679 | 0.88 | MAOB (0.71) | MAPTBCHECYP2C19MAOBCYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| EP-3110392-B1 | TOPICAL COSMETIC OR PHARMACEUTICAL COMPOSITION | LVS CAPITAL GMBH (DE) | 2020-11-25 | — | — | EP | disclosed |
| EP-3110392-A1 | TOPICAL COSMETIC OR PHARMACEUTICAL COMPOSITION | LVS-Capital GmbH (DE) | 2017-01-04 | — | — | EP | disclosed |
| WO-2015128280-A1 | TOPICAL COSMETIC OR PHARMACEUTICAL COMPOSITION | LVS-CAPITAL GMBH (DE) | 2015-09-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAPT 3297/4885BCHE 588/4885CYP2C19 109/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885BCHE 465/4885CYP2C19 583/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAPT 3512/4885BCHE 465/4885CYP2C19 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.